1. Bachus, Scott, Akkerman, Nikolas, Fulham, Lauren, Rempel, Jordan, Pelka, Peter. . ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair. In Nucleic acids research, 52, 5658-5675. doi:10.1093/nar/gkae208. https://pubmed.ncbi.nlm.nih.gov/38520408/
2. Zhang, Dingxiao, Jiang, Pingping, Xu, Qinqin, Zhang, Xiaoting. 2011. Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth. In The Journal of biological chemistry, 286, 17746-54. doi:10.1074/jbc.M110.206029. https://pubmed.ncbi.nlm.nih.gov/21454576/
3. Pirnie, Stephan P, Osman, Ahmad, Zhu, Yinzhou, Carmichael, Gordon G. . An Ultraconserved Element (UCE) controls homeostatic splicing of ARGLU1 mRNA. In Nucleic acids research, 45, 3473-3486. doi:10.1093/nar/gkw1140. https://pubmed.ncbi.nlm.nih.gov/27899669/
4. Chan, Seow Neng, Pek, Jun Wei. 2022. Distinct biogenesis pathways may have led to functional divergence of the human and Drosophila Arglu1 sisRNA. In EMBO reports, 24, e54350. doi:10.15252/embr.202154350. https://pubmed.ncbi.nlm.nih.gov/36533631/
5. Li, Fangyuan, Li, Jianfang, Yu, Junxian, Li, Yuan-Yuan, Liu, Bingya. 2021. Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data. In EBioMedicine, 69, 103436. doi:10.1016/j.ebiom.2021.103436. https://pubmed.ncbi.nlm.nih.gov/34157484/
6. Magomedova, Lilia, Tiefenbach, Jens, Zilberman, Emma, Blencowe, Benjamin J, Cummins, Carolyn L. . ARGLU1 is a transcriptional coactivator and splicing regulator important for stress hormone signaling and development. In Nucleic acids research, 47, 2856-2870. doi:10.1093/nar/gkz010. https://pubmed.ncbi.nlm.nih.gov/30698747/
7. Yao, Fenyong, Huang, Shisheng, Liu, Jiahui, Huang, Xingxu, He, Shuijin. 2023. Deletion of ARGLU1 causes global defects in alternative splicing in vivo and mouse cortical malformations primarily via apoptosis. In Cell death & disease, 14, 543. doi:10.1038/s41419-023-06071-w. https://pubmed.ncbi.nlm.nih.gov/37612280/
8. Lévy, J, Haye, D, Marziliano, N, Verloes, A, Tabet, A-C. 2018. EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder. In Clinical genetics, 93, 1141-1147. doi:10.1111/cge.13234. https://pubmed.ncbi.nlm.nih.gov/29508392/
9. Zhao, Wei, Zhao, Yingyan, Chen, Ling, Sun, Yan, Fan, Sumei. 2022. miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1. In Computational and mathematical methods in medicine, 2022, 2329576. doi:10.1155/2022/2329576. https://pubmed.ncbi.nlm.nih.gov/35082911/
10. Chuang, Gwo-Tsann, Liu, Pi-Hua, Chyan, Tsui-Wei, Shen, Chen-Yang, Chang, Yi-Cheng. 2020. Genome-wide association study for circulating fibroblast growth factor 21 and 23. In Scientific reports, 10, 14578. doi:10.1038/s41598-020-71569-8. https://pubmed.ncbi.nlm.nih.gov/32884031/